Human Lung Responses to Respiratory Pathogens
Completed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Respiratory Infection
In brief
For most individuals, the lung has a remarkable ability to deal with exposure to a variety of inhaled bacteria. Some individuals, however, do have recurrent bacterial infections, usually in the form of acute or chronic bronchitis and, in some instances, pneumonia. The reasons for this variability in bacterial infections between otherwise healthy subjects, between types of lung disease, and within the same type of lung disease are poorly understood. Variability in susceptibility to bacterial infections is partially explained by differences in exposure to infectious agents, genetic susceptibility and innate (or early) immune responses. It is of interest that the incidence and severity of bacterial infections is greatest during the winter months. Other than viral infections, there are few variables that change with season. Vitamin D is one known immune modulator with a seasonal periodicity. The hypothesis of this study is that levels of vitamin D are an important determinant of the innate defense of the lung against inhaled bacteria. The investigators further postulate that vitamin D has effects on the innate immune function of both alveolar macrophages and lung epithelial cells.
Key facts
- Study ID
- NCT01967628
- Run by
- University of Iowa
- People needed
- 98
- Starts
- 2007-06-01
- Expected to finish
- 2010-10-01
- Last updated by the study team
- 2018-03-29
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Signed informed consent form Age 18 - 60 Healthy nonsmoker, healthy smoker Forced expiratory volume in 1 second (for smokers) > 60% predicted.
You may not qualify if…
- Pregnant or breastfeeding
- Medications (with the exception of hormonal birth control, thyroid medication or prespecified over the counter medications), including multi-vitamins and any preparation that contains vitamin D
- Asthma
- Heart disease
- Diabetes
- Previous positive tuberculin skin test, or previous diagnosis of tuberculosis
- Recent respiratory tract infection
- History of multiple bouts of pneumonia
- Allergies to caines, atropine, or a history of adverse reaction to narcotics
- Other factors that increase the risk of bronchoscopy
- Evidence of acute bronchitis within the past 2 weeks
Where it is running
- University of Iowa — Iowa City, Iowa, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.